Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Multiple Myeloma 1Carcinoma, Ovarian Epithelial 1

Interventions

Cyclophosphamide 3fludarabine 2Paclitaxel 2Carboplatin 2Bevacizumab 2trastuzumab deruxtecan 1pembrolizumab 1olaparib 1niraparib 1mirvetuximab soravtansine 1irinotecan sucrosofate 1fludarabine phosphate 1denileukin diftitox 1Tinzaparin 1Propranolol 1Palliative Care 1Nivolumab 1Neoadjuvant Therapy 1Music Therapy 1Losartan 1Indocyanine Green 1GEN-1 1Etodolac 1E7777 fusion protein 1Clarithromycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Ovarian Epithelial × Clarithromycin × 30 days × Clear all
NCT07341100 2026-06-01

Study to Evaluate the Preliminary Efficacy of SKB264 and the Effect of Clarithromycin on the PK of SKB264 in OC

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

Phase 2 Active not recruiting
20 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial

Data powered by HemOnc (CC BY 4.0) Colophon âš¡